Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
JHLT Open|March 27, 2025
Pulmonary hypertension in Finland 2008-2020: A descriptive real-world cohort study (FINPAH)Markku Pentikäinen, Piia Simonen, Helena Tuunanen, et al.
Pulmonary Circulation|February 5, 2025
Treatment pathways in Finnish patients with pulmonary arterial hypertension (PAH) or chronic thromboembolic pulmonary hypertension (CTEPH)Markku Pentikäinen, Piia Simonen, Pauliina Leskelä, et al.
The Journal of Gene Medicine|April 27, 2011
Switching the fiber knob of oncolytic adenoviruses to avoid neutralizing antibodies in human cancer patientsMari Raki, Merja Sarkioja, Sophie Escutenaire, et al.
Journal of Molecular and Cellular Cardiology|June 8, 2024
Presenilin-1 ΔE9 mutation associated sarcoplasmic reticulum leak alters [Ca<sup>2+</sup>]<sub>i</sub> distribution in human iPSC-derived cardiomyocytesNikolay Naumenko, Jussi T Koivumäki, Olesia Lunko, et al.
Frontiers in Physiology|February 23, 2018
Structural Immaturity of Human iPSC-Derived Cardiomyocytes: <i>In Silico</i> Investigation of Effects on Function and Disease ModelingJussi T Koivumäki, Nikolay Naumenko, Tomi Tuomainen, et al.
Oncoimmunology|April 9, 2016
Oncolytic virotherapy for treatment of breast cancer, including triple-negative breast cancerSimona Bramante, Anniina Koski, Ilkka Liikanen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 5, 2016
Predictive and Prognostic Clinical Variables in Cancer Patients Treated With Adenoviral Oncolytic ImmunotherapyKristian Taipale, Ilkka Liikanen, Anniina Koski, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 7, 2015
T-cell subsets in peripheral blood and tumors of patients treated with oncolytic adenovirusesKristian Taipale, Ilkka Liikanen, Juuso Juhila, et al.
Pageof 5